-
Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma
18 Dec 2024 16:06 GMT
… (SHARP) trials, sorafenib significantly improved the prognosis … in patients taking sorafenib primarily included gastrointestinal, … between ferroptosis and sorafenib resistance, suggesting ferroptosis … renal, liver, and lung cancers, and has been implicated …
-
Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis
26 Nov 2024 06:14 GMT
… obtained after sorafenib usage in sorafenib-resistant patients … -shRNA/sorafenib group versus sorafenib-treated group, … shRNA/sorafenib group.
.
Discussion
Sorafenib represents a … non-small cell lung cancer progression via destabilizing IGF2BPs …
-
Molecular Switches as Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application Market Research Report 2025 with Top 20 Drugs Sales Targeting Molecular Switches 2022-2024 - ResearchAndMarkets.com
27 Jan 2025 15:02 GMT
… Therapeutics: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer
Molecular … cells.
This system releases both sorafenib, which induces ferroptosis, and an … .3 Colorectal cancer
6.4 Lung Cancer
6.5 Gastric Cancer
7 …
-
Clinical Significance and Molecular Annotation for PD-L1 Negative Advanced Non-Small Cell Lung Cancer with Sensitivity to Responsive to Dual PD-1/CTLA-4 Blockade
06 Sep 2024 05:53 GMT
… and mortality rates of lung cancer have been steadily increasing … with various malignancies, including lung cancer.35 Finally, we combined … carcinoma previously treated with sorafenib: the checkmate 040 … with non-small-cell lung cancer (CheckMate 9LA): an …
-
Mesoporous Graphene Oxide Nanocomposite Effective for Combined Chemo/Photo Therapy Against Non-Small Cell Lung Cancer
24 Jul 2024 08:34 GMT
… Cancer Epidemiology Report (2024), lung cancer ranks as the most … to load chemotherapy drugs Sorafenib and FeS2 nanoparticles for … , China) and human lung cancer A549 cells were obtained from … T790M positive non-small cell lung cancer: OSCILLATE. Nat Commun. …
-
Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) Compared to Opdivo Monotherapy...
25 Jan 2025 15:13 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … been previously treated with sorafenib. This indication is … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
03 Jun 2024 12:19 GMT
… to biomarkers.
About Lung Cancer
Lung cancer is the leading cause … positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … been previously treated with sorafenib. This indication is … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Elevar Therapeutics Presents Results from Post-Hoc Analysis of CARES-310 Study Evaluating the Impact of Viral and Non-Viral Etiology on Survival in Hepatocellular Carcinoma
24 Jan 2025 15:41 GMT
… camrelizumab plus rivoceranib vs. sorafenib as a first-line … plus rivoceranib compared with sorafenib in patients with non … tumors (including liver cancer, lung cancer, gastric cancer, and breast … of non-small cell lung cancer (non-squamous and squamous …
-
Enhanced Antitumor Efficacy and Reduced Toxicity in Colorectal Cancer Using a Novel Multifunctional Rg3- Targeting Nanosystem Encapsulated with Oxaliplatin and Calcium Peroxide
24 Jan 2025 10:21 GMT
… L, et al. Sorafenib-encapsulated liposomes to activate hypoxia … Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via … attenuates cisplatin resistance in lung cancer by downregulating PD-L1 … advanced non-small cell lung cancer in China: a …
-
Roche Alecensa gets USFDA nod for ALK-positive early-stage lung cancer
20 Apr 2024 09:27 GMT
… the European Medicines Agency.
Lung cancer is one of the leading … non-small cell lung cancer (NSCLC) and small-cell lung cancer. NSCLC is … despite adjuvant chemotherapy. Treating lung cancer early, before it has … Atezolizumab, Lenvatinib, and Sorafenib Study
About
© 1995-2025